Home
About
Overview
Sharing Data
ORCID
Help
History (1)
FLT3 Agonists and Secondary Hematopoietic Malignancies: A Potential Class Effect.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FLT3 Agonists and Secondary Hematopoietic Malignancies: A Potential Class Effect.
FLT3 Agonists and Secondary Hematopoietic Malignancies: A Potential Class Effect. Clin Cancer Res. 2024 Jul 15; 30(14):2857-2859.
View in:
PubMed
subject areas
Dendritic Cells
fms-Like Tyrosine Kinase 3
Hematologic Neoplasms
Humans
Leukemia, Myeloid, Acute
Neoplasms, Second Primary
authors with profiles
Michael Drazer